Early Microbiologic Markers of Pulmonary Tuberculosis Treatment Outcomes.

Earlier biomarkers of pulmonary tuberculosis (PTB) treatment outcomes are critical to monitor shortened anti-TB treatment (ATT). To identify early microbiologic markers of unfavorable TB treatment outcomes. We performed a subanalysis of 2 prospective TB cohort studies conducted from 2013 to 2019 in India.

Tuberculosis Pathways to Care and Transmission of Multidrug Resistance in India.

India is experiencing a regional increase in cases of multidrug-resistant tuberculosis (MDR-TB). Given the complexity of MDR-TB diagnosis and care, we sought to address key knowledge gaps in MDR risk factors, care delays, and drivers of delay to help guide disease control. From January 2018 to September 2019, we conducted interviews with adults registered with the National TB Elimination Program for MDR ( = 128) and non-MDR-TB ( = 269) treatment to quantitatively and qualitatively study care pathways.